Enterovirus 71 human immunoglobulin (pH4, Chengdu Rongsheng Pharmaceuticals)
肠病毒71型人免疫球蛋白（pH4，成都蓉生药业）
Report date: 2023/06/28 17:07:34
Base Information
Drug NameEnterovirus 71 human immunoglobulin (pH4, Chengdu Rongsheng Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesChengdu Rongsheng Pharmaceuticals Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesN/A
Inactive CompaniesChengdu Rongsheng Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A